(Q61986522)

English

Moderate hypofractionation and simultaneous integrated boost with volumetric modulated arc therapy (RapidArc) for prostate cancer

scientific article published on 29 September 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23053143%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Moderate hypofractionation and simultaneous integrated boost with volumetric modulated arc therapy (RapidArc) for prostate cancer. Report of feasibility and acute toxicity (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23053143%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23053143%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23053143%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Marta Scorsetti

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23053143%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

author name string

A Fogliata

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23053143%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

P Navarria

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23053143%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

A Tozzi

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23053143%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

F Lobefalo

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23053143%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

G Reggiori

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23053143%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

A Clivio

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23053143%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

L Cozzi

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23053143%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

publication date

29 September 2012

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23053143%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Strahlentherapie und Onkologie

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23053143%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

188

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23053143%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23053143%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

990-996

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23053143%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

https://scigraph.springernature.com/pub.10.1007/s00066-012-0171-7

0 references

Volumetric modulated arc therapy: IMRT in a single gantry arc.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23053143

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Cleveland Clinic experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/23053143

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dosimetric predictors of diarrhea during radiotherapy for prostate cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23053143

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose-fractionation sensitivity of prostate cancer deduced from radiotherapy outcomes of 5,969 patients in seven international institutional datasets: α/β = 1.4 (0.9-2.2) Gy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23053143

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Image-guided radiation therapy: a new era for the radiation oncologist?

1 reference

https://pubmed.ncbi.nlm.nih.gov/23053143

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The radiobiology of prostate cancer including new aspects of fractionated radiotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23053143

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Volumetric modulated arc therapy for delivery of prostate radiotherapy: comparison with intensity-modulated radiotherapy and three-dimensional conformal radiotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23053143

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/23053143

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evidence for efficacy without increased toxicity of hypofractionated radiotherapy for prostate carcinoma: early results of a Phase III randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/23053143

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Will SBRT replace conventional radiotherapy in patients with low-intermediate risk prostate cancer? A review

1 reference

https://pubmed.ncbi.nlm.nih.gov/23053143

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23053143

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of a four-week hypofractionated external beam radiotherapy regimen for prostate cancer: report on acute toxicity.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23053143

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose-volume relationships for acute bowel toxicity in patients treated with pelvic nodal irradiation for prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23053143

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The GETUG 70 Gy vs. 80 Gy randomized trial for localized prostate cancer: feasibility and acute toxicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/23053143

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/23053143

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Observations on real-time prostate gland motion using electromagnetic tracking.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23053143

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospective phase II trial of cetuximab plus VMAT-SIB in locally advanced head and neck squamous cell carcinoma. Feasibility and tolerability in elderly and chemotherapy-ineligible patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/23053143

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute morbidity related to treatment volume during 3D-conformal radiation therapy for prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23053143

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early clinical experience of radiotherapy of prostate cancer with volumetric modulated arc therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23053143

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose-escalated simultaneous integrated-boost treatment of prostate cancer patients via helical tomotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23053143

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II Trial of Hypofractionated Image-Guided Intensity-Modulated Radiotherapy for Localized Prostate Adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/23053143

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer statistics, 2012

1 reference

https://pubmed.ncbi.nlm.nih.gov/23053143

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hypofractionation for prostate cancer radiotherapy—what are the issues?

1 reference

https://pubmed.ncbi.nlm.nih.gov/23053143

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intensity-modulated radiotherapy as primary treatment for prostate cancer: acute toxicity in 114 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/23053143

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I-II study of hypofractionated simultaneous integrated boost with tomotherapy for prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23053143

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Toxicity after three-dimensional radiotherapy for prostate cancer with RTOG 9406 dose level IV.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23053143

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hypofractionation for prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23053143

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio), similar to late-responding normal tissue

1 reference

https://pubmed.ncbi.nlm.nih.gov/23053143

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Optimization of conformal radiation treatment of prostate cancer: Report of a dose escalation study

1 reference

https://pubmed.ncbi.nlm.nih.gov/23053143

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized trial comparing hypofractionated and conventionally fractionated three-dimensional external-beam radiotherapy for localized prostate adenocarcinoma : a report on acute toxicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/23053143

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hypofractionated conformal radiotherapy in carcinoma of the prostate: five-year outcome analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23053143

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prospective phase III randomized trial of hypofractionation versus conventional fractionation in patients with high-risk prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23053143

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized Trial Comparing Two Fractionation Schedules for Patients With Localized Prostate Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23053143

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q61986522&oldid=1415439600"